Podcasts about clinical practice

This week, we look at new evidence on oral cholesterol-lowering therapy, the evolving role of beta-blockers after myocardial infarction, and advances in breast and prostate cancer treatment. We review the inherited risk of coronary disease. We also work through a revealing diagnostic case in a young woman and reflect on science under pressure, corporatized insurance, the reach of FDA law, and what it means to live with life-sustaining technology.

Stress fractures are common injuries in athletes and military recruits, that's' understandable- based on the physical forces placed on the long bones. A stress fracture can be defined as a partial or complete fracture of the bone that is a result from repeated application of stress lower than that required to fracture the bone in a single loading situation. In pregnancy, the body is subjected to various physiological changes that make women more vulnerable. In this pregnancy, we will highlight a REAL patient case which our team cared for on the inpatient service where a simple cough at 34 weeks leads to a painful spontaneous rib fracture! Is there any data published on this? Are serum tests for bone turn-over required as part of this workup? Listen in for clinical pearls!1. 1962: Long A.E.: “Stress fracture of the ribs associated with pregnancy”. Surg. Clin. North Am., 1962, 42, 909.2. 2000: Baitner AC, Bernstein AD, Jazrawi AJ, Della Valle CJ, Jazrawi LM. Spontaneous rib fracture during pregnancy. A case report and review of the literature. Bull Hosp Jt Dis. 2000;59(3):163-5. PMID: 11126720. https://pubmed.ncbi.nlm.nih.gov/11126720/3. 2015: Rib stress fractures in pregnancy: a case report and review of literature. chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/file:///C:/Users/hchapa/Downloads/1575956493464-5157163%20(1).pdf4. Zhang Y, Li R, Zhang J, Zhou W, Yu F. Changes in Serum Concentrations of Bone Turnover Markers in Healthy Pregnant Women. International Journal of Clinical Practice. 2023.

In this episode of the Innovations and Clinical Implementation podcast, hosts Dr. Lexi Gonzales and Tom Blue interview Dr. Sundeep Dugar, a pharmaceutical drug hunter with nearly 40 years of experience in small molecule discovery who serves as the co-founder and Chief Scientific Officer at Blue Oak Nutraceuticals. The conversation focuses on the development of Mitocatalyst, a precision-formulated epicatechin designed to mimic the mitochondrial biogenesis normally triggered by exercise. Dr. Dugar reveals his breakthrough discovery that exercise-induced Reactive Oxygen Species (ROS) signal the mitochondria to produce a specific steroid—11-beta hydroxyprogesterone—and explains how Mitocatalyst utilizes nanomolar doses of epicatechin to molecularly mimic this steroid, distinguishing it from high-dose antioxidant protocols that paradoxically blunt these beneficial signals. The discussion uses the metaphor of building a "fireplace" (mitochondria) to burn "firewood" (nutrition), positioning the supplement as a critical intervention for aging patients or those unable to exercise. For access to episode resources: https://sites.google.com/ovationlab.com/innovationsinclinicalimplement/home

Send us a textStep inside the room where it's happening. This recording captures the groundbreaking AI panel discussion from the 2026 Delphi Neonatal Innovation Conference, held live on Monday afternoon. Leading experts Dr. Jim Barry (University of Colorado), Dr. Thao Ho (UCSF), Lindsey Knake (University of Iowa), Selva Selvaraj (Nicklaus Children's Health System), and Dr. Ryan McAdams (University of Wisconsin-Madison) tackle the most pressing questions about AI in the NICU.From predictive models for sepsis and NEC to AI scribes that transform documentation, our panelists explore what's actually working today versus what remains science fiction. They discuss the challenge of generalizing AI across different units, navigating ethics and bias, designing tools for families, and envisioning what neonatal care will look like in ten years. If you're wondering whether we're ready for AI-driven clinical decisions—or how to avoid “AI fatigue”— this panel discussion is for you!Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

This week, we explore new therapies to reduce pancreatitis risk in severe hypertriglyceridemia, advances in breast cancer treatment, and long-term results of gene therapy for hemophilia B. We discuss vision-threatening vascular emergencies, the mental health effects of firearm injury on families, and care for peripheral artery disease. We also follow a revealing diagnostic case in an older woman with respiratory failure. Perspectives reflect on hypertension control, immunization access, chronic disease policy, and on the inherited risk of disease.

Robert Kocher is an adjunct professor at the Stanford University School of Medicine, a nonresident senior scholar at the University of Southern California Schaeffer Institute, and a partner at Venrock. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.P. Kishore and R. Kocher. The Hypertension Control Paradox — Why Is America Stuck? N Engl J Med 2026;394:417-420.

Comments or feedback? Send us a text! Empathy is widely viewed as the cornerstone of effective therapy—but what if we've been misunderstanding it all along?In this episode, Dr. Pete Kelly sits down with Dr. Douglas Flemons, to discuss his new book Empathic Engagement in Clinical Practice. Flemons challenges the common assumption that empathy is something therapists simply have, reframing it instead as something we do—moment by moment, in relationship.Together, they explore empathy as an active, relational process; unpack the critical distinctions between empathy, sympathy, and compassion; and examine why well-intentioned empathic efforts can sometimes miss the mark or even undermine the therapeutic alliance. The conversation also addresses therapist burnout, emotional boundaries, and how clinicians can engage deeply with clients without overidentifying or becoming emotionally depleted.This episode is essential listening for clinicians who want to refine their relational skills, strengthen therapeutic presence, and practice empathy in a way that is both clinically effective and personally sustainable.

In this episode, we explore evolving evidence on anticoagulation after atrial fibrillation ablation, long-term outcomes with immunotherapy for melanoma, and promising new treatments for hepatitis D and triple-negative breast cancer. We review advances in physiologic pacing for heart failure and work through a challenging case involving fever, rash, and neurologic symptoms. An article considers fairness for late-career physicians, and Perspectives discuss misconceptions about autism, access to contraception, and the financial pressures shaping health care.

Tara Eicher is a postdoctoral research fellow in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Eicher, J. Quackenbush, and A. Ne'eman. Challenging Claims of an Autism Epidemic — Misconceptions and a Path Forward. N Engl J Med 2026;394:313-315.

Unlock the secrets behind squat biomechanics in this must-listen episode of the "NASM CPTPodcast" with host, and NASM Master Instructor, Rick Richey. Whether you're a fitness veteran or just starting your strength journey, this episode dives deep into the science—and myths—about squats, backed by the latest research. Curious about why your torso leans differently during squats, or how changing your foot position impacts muscle activation? Rick breaks down the impact of tibia-torso angles, foot position (should you turn your toes out?), and squat depth on your muscles and overall performance. Learn how “butt wink,” squat depth, and even partial squats play a role in hypertrophy and athletic performance—and what matters most for avoiding injury. Packed with evidence from studies like Barack et al. (2011) and Strab & Powers (2024), this episode smashes old rules and reveals how to tailor your squat technique for optimal results, safety, and YOUR body's limitations. Worried about knee pain, back issues, or if deeper squats are better? The answers may surprise you! Plus, get actionable tips on how to assess and improve your range of motion, how personal anatomy affects squat form, and why consistency often beats perfection in your training routine. Episode References: Straub, R. K., & Powers, C. M. (2024). A Biomechanical Review of the Squat Exercise: Implications for Clinical Practice. International journal of sports physical therapy, 19(4), 490–501. https://doi.org/10.26603/001c.94600 Barrack Adam J, Straub Rachel K, Cannon Jordan, Powers Christopher M. International Journal of Sports Science & Coaching. 4. Vol. 16. SAGE Publications; the relative orientation of the trunk and tibia can be used to estimate the demands on the hip and knee extensors during the barbell back squat; pp. 1004–1010. If you like what you just consumed, leave us a 5-star review, and share this episode with a friend to help grow our NASM health and wellness community! The content shared in this podcast is solely for educational and entertainment purposes. It is not intended to be a substitute for professional advice, diagnosis, or treatment. Always seek out the guidance of your healthcare provider or other qualified professional. Any opinions expressed by guests and hosts are their own and do not necessarily reflect the views of NASM. CTA: Introducing NASM One, the membership for trainers and coaches. For just $35/mo., get unlimited access to over 300 continuing education courses, 50% off additional certifications and specializations, EDGE Trainer Pro all-in-one coaching app to grow your business, unlimited exam attempts and select waived fees. Stay on top of your game and ahead of the curve as a fitness professional with NASM One. Click here to learn more. https://bit.ly/4ddsgrm

This week, we explore new evidence on managing asymptomatic carotid stenosis, restoring vision in advanced macular degeneration, and preventing migraine in children. We discuss innovative cellular therapy for autoimmune disease, review sudden cardiac arrest in athletes, and describe a case of severe systemic infection with vision loss. Perspectives examine global tobacco risks, the future of telehealth payment, Medicare coverage of new technologies, and the things physicians carry.

Dr. Aaron Zelikovich discusses the utility of neurofilament light chain as a serum biomarker in peripheral neuropathy.  Show citation: Karam C. Clinical Utility of Serum Neurofilament Light Chain in Peripheral Neuropathy. Muscle Nerve. 2026;73(1):86-92. doi:10.1002/mus.70073 Show transcript: Dr. Aaron Zelikovich: Welcome to today's neurology minute. My name is Aaron Zelikovich, a neuromuscular specialist at Lenox Hill Hospital in New York City. Today, we will discuss a recent article on the utility of neurofilament light chain as a serum biomarker in peripheral neuropathy. It has been studied in other neurological diseases like ALS and multiple sclerosis, as in the 2024 study by Robert Fox et al, which highlighted the limitations of serum neurofilament light chain in patients with multiple sclerosis, since the elevation was inconsistent and tended to occur weeks after MRI changes, and was really only found to be helpful in certain clinical situations. The study we highlight today is a single-center retrospective study that highlights the opportunities and limitations of using serum neurofilament light chain as a biomarker to monitor treatment response and peripheral neuropathy. Serum neurofilament light chain has been shown as an indicator of neuronal injury in both central and peripheral nervous system disease that has been associated with axonal injury or degeneration. It is now commercially available. The authors in this study provide a real-world single-center retrospective study that looked at various forms of peripheral neuropathy over 12 months. Patients had to be evaluated and meet criteria for peripheral neuropathy with either genetic testing, nerve conduction studies, and/or clinical exams. Neuropathies included TTR amyloid, vasculitis, CMT, CIDP, GBS, and anti-MAG neuropathy. Patients with TTR amyloid who were treatment naive and had elevated serum neurofilament light chain showed a reduction in neurofilament light chain levels with treatment. Additionally, patients with CIDP who were treatment naive with elevated serum neurofilament light chain also showed a reduction in neurofilament light chain levels with treatment. All patients with idiopathic peripheral neuropathy had normal serum neurofilament light chain levels. However, serum neurofilament light chain can vary in patients based on age, if they have diabetes, renal dysfunction, and body weight. And this makes it really challenging to interpret it in an isolated setting. Serum neurofilament light chain is a new biomarker for peripheral neuropathies. It can be a supplemental tool in the appropriate clinical context. Future studies are needed to identify its potential to be used as a treatment response biomarker in neuropathies like CADP, GBS, and TTR amyloid. Thank you so much, and have a wonderful day. 

Tara Sklar is the faculty director of the Health Law and Policy Program at the University of Arizona James E. Rogers College of Law and associate director of telehealth law and policy at the University of Arizona College of Medicine–Tucson Arizona Telemedicine Program. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Sklar and B. Richman. Financing Telehealth — Moving Beyond Payment Parity. N Engl J Med 2026;394:211-213.

Do you know the best day to start a detoxification program in January? (HINT: It's not January 1st!) Dr. Kim Besuden, DC, CFMP shares her tips and tricks for running successful individual and group purification programs in her practice, including best days to start, what support to offer as a practitioner, and suggestions for community support opportunities. Dr. Sarah Clarke, DC, IFMCP, host of this episode, asks Dr. Besuden what clinical signs she identifies to determine if a patient needs to detox, and how to establish healthy eating habits after the progam has finished. She shares ways to establish yourself as a nutrition leader in your community and ways she supports other practitioners in growing their practices. SHOW SUMMARY 3:00 Detoxification program done by staff gives optimal support for patients 4:18 Appropriate timing for detox program after holidays is crucial for success 5:20 Single best way to reach out to your community and guide them through the process 6:45 Community support helps patients get through a detox program, virtually and in person 9:40 Celebrate the holidays guilt free and without withholding, it's the amount and quality to be mindful of 10:42 5-day flash detoxes throughout the year around holidays 12:38 Advice for patients that want to continue exercising during a detox program 14:43 Clinical signs that a patient could benefit from a detox program 16:33 Adopting new healthy habits after completing a detox program 17:20 The caffeine dilemma – when to take a break and how much to drink for optimal health benefits 19:20 Top 2 improvements patients report after completing a detox program 20:00 How detox programs support liver health 21:50 Detox programs for the whole family – teaching children life long healthy habits 24:00 Food, Movement, Blood Sugar Balance, and Sleep – tools for monitoring sleep, blood sugar and more to understand each person's biomarkers 29:34 Detoxing in community helps with compliance and offers a significant learning opportunity 30:50 I made it through the detox!… what's next? 33:40 Clinical success stories - lab markers that indicate the need for a detoxification program 39:50 Choosing your hard and meeting patients where they're at 44:10 Benefits of using an OTC CGM to learn about blood sugar regulation 45:36 Best way to establish yourself a leader in your community on nutrition 46:26 Dr. Besudan as a resource for other practitioners

This week, we explore new options in cardiovascular prevention, fish-oil supplementation in dialysis patients, RSV vaccination, and cutting-edge cellular therapy for leukemia. We discuss advances in lung cancer treatment, approaches to functional dyspepsia, and a complex case of severe infection after travel. Perspectives examine access to and cost of weight-loss drugs, the promise and risks of AI in clinical care, and what it means to care for others while carrying personal loss.

In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Wei-Wu, Executive Chairman at Human Longevity, Inc. Together, they explore how advances in genome sequencing, AI, and multi-layered diagnostics are changing the fight against age-related diseases. Wei-Wu shares why understanding your own genetic risks and combining them with other health data leads to better prevention and a longer healthspan.Wei-Wu explains the value of integrating genome sequencing, advanced imaging, and liquid biopsy to catch diseases like cancer early, before symptoms appear. He draws on real-world examples, including how combining different tests can spot cancers that single methods might miss. The conversation highlights how technology brings down costs, making once-rare insights widely available, and how each person stands to benefit from personalized risk profiles.The episode closes with practical advice: use today's tools to become the CEO of your own health. Wei-Wu urges listeners to embrace data-driven, individualized care and stresses that no single tool or habit holds all the answers. Instead, true longevity comes from a holistic, ongoing approach, one that uses all available knowledge to prevent disease and extend both life and health.Guest-at-a-Glance

Rachel Sachs is a professor of law at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina and R.E. Sachs. Insurance Coverage and Pricing of Weight-Loss Drugs in the United States. N Engl J Med 2026;394:105-107. S. Gondi, A.S. Kesselheim, and B.N. Rome. Generic Liraglutide — Overlooked but Not Forgotten. N Engl J Med. DOI: 10.1056/NEJMp2515668.

This episode explores the evolving role of ketamine in mental health care and what it means for the future of nursing practice as psychedelic-assisted therapies move toward mainstream medical use. Rebecca Ivory, DNP, MS, PMHNP-BC, Adjunct Faculty at the University of Delaware School of Nursing in Newark, Delaware, and Jennifer Graber, EdD, APRN, PMHCNS-BC, Associate Dean at the University of Delaware School of Nursing, co-authors of the NCPD article, "Ketamine infusion therapy for treatment-resistant major depressive disorder and suicidal ideation: Nursing care and considerations,"published in the December 2025 issue of Nursing share their insights.

Welcome to another episode of the Sustainable Clinical Medicine Podcast! In this episode, Dr. Zhen Chan shares his unique journey from growing up in Miami, Florida to becoming a pediatrician in Washington, DC, and ultimately venturing into the entrepreneurial side of healthcare. Dr. Chan discusses his educational background, including an MD-MBA dual degree, and how it shaped his interests in blending artistic and scientific aspects within the medical field. He delves into his clinical practice in the 'fast track' side of an emergency room and his desire to improve healthcare systems. Dr. Chan also talks about his entrepreneurial endeavors, like founding Grapevine, a community focused on healthcare workforce optimization and reducing burnout among medical professionals. Throughout the conversation, he emphasizes the importance of networking and staying updated with technological advancements to better serve patients and the healthcare community. Here are 3 key takeaways from this episode: 1. The Power of Networking in Healthcare: Dr. Chan emphasizes that building professional relationships and communities—like her Grapevine initiative—is crucial for career growth, combating burnout, and reducing social isolation among healthcare professionals. Networking is not just for business leaders; it's essential for clinicians at all stages. 2. Innovation and Entrepreneurship are Vital for Modern Physicians: Dr. Chan's journey shows that blending clinical practice with entrepreneurial thinking and process improvement (such as Six Sigma and MBA training) can help address systemic issues in healthcare. Physicians can—and should—embrace innovation to improve patient care and the healthcare system. 3. Technology and AI Can Reduce Administrative Burden: The discussion highlights how AI-powered tools (like scribing and coding assistants) are transforming healthcare by reducing administrative workload, allowing doctors to focus more on patient care. Accurate documentation and embracing new technologies are key to improving efficiency and outcomes. Meet Dr. Zhen Chan: Dr. Zhen Chan is a practicing pediatrician at Children's National Medical Center in Washington, DC and Founder/CEO of Grapevyne, a community dedicated to empowering physician autonomy and wellbeing through better networking and understanding about healthcare beyond medicine. He graduated from the University of Miami with his BS in Neuroscience and Criminology, MD, and MBA in Health Management & Policy. After completing his education, he went on to complete his pediatrics residency at New York Presbyterian Hospital-Weill Cornell Medicine, where his work in quality improvement and advocacy projects revealed a career path to impact healthcare at scale beyond the exam room. In addition to his clinical practice and his own community, he advises other healthcare startups as well focused on improving healthcare access. Connect with Dr. Zhen Chan:

[Trigger warning: trauma/animal cruelty] What is the difference between genuine empathy and feeling sympathy for someone? How often do well-intended therapists mistake comparison for true empathic engagement? What does it […] The post Empathic Engagement in Clinical Practice with Dr. Douglas Flemons [Trigger Warning: Trauma/Animal Cruelty] | POP 1324 appeared first on How to Start, Grow, and Scale a Private Practice | Practice of the Practice.

This week, we share advances in treatment for EGFR-mutated lung cancer, a brain-penetrant enzyme therapy for a rare pediatric disorder, and dual targeting of extramedullary myeloma. We review cardiogenic shock, work through a challenging diagnostic puzzle in a young woman with recurrent illness, and explore Perspectives on corporatized care, vaccine policy, AI in medicine, and where clinicians carry grief.

Ambar La Forgia is an assistant professor in the Management of Organizations group at the University of California, Berkeley Haas School of Business. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. La Forgia. From Patients to Consumers — The Corporatization of Ambulatory Care. N Engl J Med 2026;394:1-3.

Please visit answersincme.com/WFH860 to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, an expert in infectious diseases discusses RSV vaccination indications, scheduling, and uptake. Upon completion of this activity, participants should be better able to: Identify the pressing need for RSV prevention in infants (≤24 months); Compare the administration schedules and clinical indications of available RSV prophylactic agents for infants; and Review strategies to address caregiver concerns and increase uptake of RSV prophylaxis in infants.

Please visit answersincme.com/WFH860 to participate, download slides and supporting materials, complete the post test, and get a certificate. In this activity, an expert in infectious diseases discusses RSV vaccination indications, scheduling, and uptake. Upon completion of this activity, participants should be better able to: Identify the pressing need for RSV prevention in infants (≤24 months); Compare the administration schedules and clinical indications of available RSV prophylactic agents for infants; and Review strategies to address caregiver concerns and increase uptake of RSV prophylaxis in infants.

In this special end-of-year reflection episode, Dr. Diane Van Staden reviews the significant milestones of 2025 for Life Beyond Clinical Practice, celebrating the growth of the community and the evolution of the brand. She emphasizes the importance of collective transformation and outlines the vision for 2026, focusing on expansion and deeper engagement with the audience.   MORE WAYS TO CONNECT: Follow Us on Instagram: @lifebeyondclinicalpractice Follow LinkedIn page: https://www.linkedin.com/company/life-beyond-clinical-practice/  Rate and Review the show on Apple Podcasts https://podcasts.apple.com/us/podcast/life-beyond-clinical-practice-healthcare-careers-professional/id1713086617 Subscribe to the YouTube channel https://www.youtube.com/@LifeBeyondClinicalPractice 

Kelly Gwathmey, MD facilitates a debate between Christina Fournier, MD and Shafeeq Ladha, MD: Should Serum Neurofilament Light Chain or NfL be Incorporated into Routine ALS Clinical Practice?

In 2002, the National Institute of Child Health and Human Development (NICHD) proposed the 3-Tier fetal heart rate (FHR) classification system that was subsequently adopted by many organizations, categorizing tracings into three groups: Category I (normal), Category II (indeterminate), and Category III (abnormal). Recently, our podcast team received an interesting question form one of our podcast family members: “If there is a change in the fetal heart rate tracing intrapartum, but it is still in the normal range (like 120 going to 150)- and variability is normal, is that an abnormality? And what is meant by a ‘ZigZag' FHT pattern (different than marked variability)?”. That is a fantastically complex question…and we will explain the answer in this episode.1. Zullo F, Di Mascio D, Raghuraman N, Wagner S, Brunelli R, Giancotti A, Mendez-Figueroa H, Cahill AG, Gupta M, Berghella V, Blackwell SC, Chauhan SP. Three-tiered fetal heart rate interpretation system and adverse neonatal and maternal outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2023 Oct;229(4):377-387. doi: 10.1016/j.ajog.2023.04.008. Epub 2023 Apr 11. PMID: 37044237.2. Ghi T, Di Pasquo E, Dall'Asta A, et al. Intrapartum Fetal Heart Rate Between 150 and 160 BPM at or After 40 Weeks and Labor Outcome.Acta Obstetricia Et Gynecologica Scandinavica. 2021;100(3):548-554. doi:10.1111/aogs.14024.3. The 3 Tier System: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://ncc-efm.org/filz/NICHD_Reference_from_CCPR.pdf4. Jia YJ, Ghi T, Pereira S, Gracia Perez-Bonfils A, Chandraharan E. Pathophysiological Interpretation of Fetal Heart Rate Tracings in Clinical Practice. American Journal of Obstetrics and Gynecology. 2023;228(6):622-644. doi:10.1016/j.ajog.2022.05.0235. Ghi T, Di Pasquo E, Dall'Asta A, et al. Intrapartum Fetal Heart Rate Between 150 and 160 BPM at or After 40 Weeks and Labor Outcome. Acta Obstetricia Et Gynecologica Scandinavica. 2021;100(3):548-554. doi:10.1111/aogs.14024.6. Yang M, Stout MJ, López JD, Colvin R, Macones GA, Cahill AG. Association of Fetal Heart Rate Baseline Change and Neonatal Outcomes. Am J Perinatol. 2017 Jul;34(9):879-886. doi: 10.1055/s-0037-1600911. Epub 2017 Mar 16. PMID: 28301895.

This is an episode from 2022.Subscribe here or wherever you get your podcasts. If you enjoyed this podcast, join NRBS for our free webinars and continuing eduction series.Today's guide is Ruth Cohn. Ruth is a psychotherapist who has been practicing neurofeedback since 2009. She has studied the dynamics of trauma and neglect, and worked with survivors; their intimate partners and families since 1998. Ruth is the author of three books: Working with the Developmental Trauma of Childhood Neglect: Using Psychotherapy and Attachment Theory Techniques in Clinical Practice; Coming Home to Passion: Restoring Loving Sexuality in Couples with Histories of Childhood Trauma and Neglect; and Out of My Mind: Late Night Contemplations About Trauma and Neglect, Book 1.In this episode, Ruth discusses trauma, with a focus on the traumatic response brought about by chronic neglect. Even young infants are sensitive to facial expressions, and infants who develop avoidant attachment relationships with their primary caregivers may be at higher risk for neglect-based trauma. Please rate us and leave reviews. It really helps get us to more listeners.This podcast is produced by the Northeast Region Biofeedback Society. NRBS is an organization for professionals, students, and everyone interested in neurofeedback, biofeedback, and whole body health.Learn more about Dr. Saul Rosenthal at advancedbehavioral.care.Contact us at healthybrain@nrbs.org.Our theme music is Catch It by Coma-MediaThe Healthy Brain Happy Body logo was designed by Alexandra VanDerlyke. Our heartfelt thanks to her and the rest of the team at Collectively Rooted.#biofeedback #neurofeedback #nrbs

Sarah shares the intersection of disordered eating and trauma. Episode Show Notes: kayladas.com/episode148 Sarah's Feel Safe with Food: The Science-Backed Way to Make Eating a Non-Issue Masterclass: sarahberneche.com/feel-safe-food-masterclass Free Private Practice Therapists Community: facebook.com/groups/exclusiveprivatepracticecommunity Comprehensive Review of Mature Minor Assessments in Clinical Practice: kayladas.com/mature-minors-workshop Credits & Disclaimers Music by ItsWatR from Pixabay The Designer Practice Podcast and Evaspare Inc. has an affiliate and/or sponsorship relationship for advertisements in our podcast episodes. We receive commission or monetary compensation, at no extra cost to you, when you use our promotional codes and/or check out advertisement links.

Episode 329 hosts Dr Ferial Fanian (Dermatologist from Paris, France) In our 'Masterclass Series' we host global experts to teach us about fillers, bio-stimulators, bio-remodellers, polynucleotides, exosomes and other products. (For toxin insights, check out our other mini-series, 'The Tox Talks') In Chapter 11 we go on a deep dive into the science of 'biostimulation' . With collagen stimulation now a seemingly generic term used for many new products launched, we aim to differentiate how these products can be classified and how they actually biostimulate. We also cover some basics of daily skincare, skin analysis, skin hydration and the history of NCTF (New Cellular Treatment Factor 135 HA). 00:00 Introduction 00:40 Special Guest: Dr Ferial Fanian 01:06 Event Experience and Masterclass Topic 01:52 Dr Ferial's Background and Expertise 02:55 Role with Filmed and Clinical Practice 05:56 Understanding Biostimulation 08:44 Categories of Biostimulation Products 18:10 Skin Health and Analysis 25:03 Patient Consultations and Objective Measurements 25:29 The Importance of Quantification in Dermatology 25:49 Investing in Medical Devices 25:58 Budgeting for Equipment 26:19 Community and Support for Injectors 27:12 Priming vs. Biostimulation 28:10 Daily Skincare Routine 28:37 The Role of Hydration and Defense in Skincare 29:48 Adapting Skincare to Seasons and Hormonal Changes 30:42 The Importance of Changing Skincare Products 33:19 Cosmeceuticals and Priming 33:45 Injectables and Hydration 34:55 Understanding NCTF and Cellular Scaffolds 41:05 The Role of Hyaluronic Acid in Skincare 48:23 Future of Injectable Products 50:07 Conclusion and Final Thoughts SUBSCRIBE TO OUR ONLINE PLATFORM FOR WEEKLY EDUCATION & NETWORKING CLICK HERE TO BROWSE OUR IA OFFERS FOR DISCOUNTS & SPECIALS CLICK HERE IF YOU'RE A BRAND OR COMPANY & WANT TO WORK WITH US CLICK HERE TO APPLY TO BE A GUEST ON OUR PODCAST CONTACT US

This week, we look at ctDNA-guided immunotherapy for bladder cancer, cardiovascular outcomes with tirzepatide, and evidence that one HPV vaccine dose may be enough. We explore high-dose rifampin for tuberculous meningitis, review measles amid rising outbreaks, and follow a challenging case of gastrointestinal bleeding. Essays examine how clinicians navigate post-Dobbs care, tobacco harm among people with mental illness, congenital syphilis, and sustaining medical research.

After three years (almost) and more than 140 episodes, a pattern has become impossible to ignore: better outcomes don't come from doing more, they come from seeing more clearly.In this episode of the Unreal Results podcast, I zoom out and reflect on the themes that shaped this year of conversations, teaching, and clinical work. We explore why the body's wisdom consistently points us toward simplicity, how assessment precision creates clarity instead of overwhelm, and why confidence grows when you trust what the body is already telling you.In this episode, you'll learn:Why assessment should create freedom, not complexity, in clinical decision-makingHow better specificity makes treatment lighter, faster, and more effectiveWhat happens when you stop chasing tools and start trusting the body's directionHow a whole-organism assessment changes both outcomes and clinician confidenceThis episode is a reminder that you don't need to do more to get better results — you need to listen better and let assessment lead the way.Resources & Links Mentioned In This Episode:Episode 42: The Fundamental Attribution Error and Why You May be the Problem, Not Your ClientEpisode 119: Guaranteeing Results... Until You Can'tEpisode 125: You're Already Treating The Viscera... You Just Don't Know ItEpisode 131: Raising The Bar On Patient OutcomesLearn the LTAP® In-Person in one of my upcoming coursesConsidering the viscera as a source of musculoskeletal pain and dysfunction is a great way to ensure a more true whole body approach to care, however it can be a bit overwhelming on where to start, which is exactly why I created the Visceral Referral Cheat Sheet. This FREE download will help you to learn the most common visceral referral patterns affecting the musculoskeletal system. Download it at www.unrealresultspod.com=================================================Watch the podcast on YouTube and subscribe!Join the MovementREV email list to stay up to date on the Unreal Results Podcast and MovementREV education. Be social and follow me:Instagram | Facebook | Twitter | YouTube

Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391.

This is an episode from 2022.Subscribe here or wherever you get your podcasts. If you enjoyed this podcast, join NRBS for our free webinars and continuing eduction series.Today's guide is Ruth Cohn. Ruth is a psychotherapist who has been practicing neurofeedback since 2009. She has studied the dynamics of trauma and neglect, and worked with survivors; their intimate partners and families since 1998. Ruth is the author of three books: Working with the Developmental Trauma of Childhood Neglect: Using Psychotherapy and Attachment Theory Techniques in Clinical Practice; Coming Home to Passion: Restoring Loving Sexuality in Couples with Histories of Childhood Trauma and Neglect; and Out of My Mind: Late Night Contemplations About Trauma and Neglect, Book 1.In this episode, Ruth discusses trauma, with a focus on the traumatic response brought about by chronic neglect. Even young infants are sensitive to facial expressions, and infants who develop avoidant attachment relationships with their primary caregivers may be at higher risk for neglect-based trauma. Please rate us and leave reviews. It really helps get us to more listeners.This podcast is produced by the Northeast Region Biofeedback Society. NRBS is an organization for professionals, students, and everyone interested in neurofeedback, biofeedback, and whole body health.Learn more about Dr. Saul Rosenthal at advancedbehavioral.care.Contact us at healthybrain@nrbs.org.Our theme music is Catch It by Coma-MediaThe Healthy Brain Happy Body logo was designed by Alexandra VanDerlyke. Our heartfelt thanks to her and the rest of the team at Collectively Rooted.#biofeedback #neurofeedback #nrbs

Send us a message with this link, we would love to hear from you. Standard message rates may apply. In this episode of Your Checkup, we break down lipoprotein(a) — a largely inherited form of cholesterol that can significantly increase the risk of heart disease and stroke, even when standard cholesterol numbers look normal. We talk about what Lp(a) is, why it matters, who should be tested, and how it helps explain “unexpected” heart events in otherwise healthy people. While Lp(a) can't currently be lowered with diet or exercise, knowing your level allows you and your care team to be more intentional about prevention by aggressively managing other risk factors like LDL cholesterol, blood pressure, and diabetes. We also discuss what the numbers mean, why most people only need to be tested once, and the promising treatments currently being studied that may change care in the future. References (for Show Notes)Nordestgaard BG, Langsted A. Lipoprotein(a) and Cardiovascular Disease. Lancet. 2024;404(10459):1255-1264.Reyes-Soffer G, et al. AHA Scientific Statement on Lipoprotein(a). Arterioscler Thromb Vasc Biol. 2022;42(1):e48-e60.Di Fusco SA, et al. Lipoprotein(a): Risk Factor and Emerging Target. Heart. 2022;109(1):18-25.Nasrallah N, et al. Lp(a) in Clinical Practice. Eur J Clin Invest. 2025:e70127.Greco A, et al. Lipoprotein(a) as a Pharmacological Target. Circulation. 2025;151(6):400-415.Bess C, Mehta A, Joshi PH. All We Need to Know About Lipoprotein(a). Prog Cardiovasc Dis. 2024;84:27-33.Support the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

This week, we look at new studies on high-dose influenza vaccines for older adults, antiplatelet therapy after coronary surgery, and HER2-targeted immunotherapy for advanced bladder cancer. We review complex regional pain syndrome and a pediatric case of fever and rash. We also explore FDA innovation and safety, aspirin's role in metastasis prevention, the meaning of “the good doctor,” smallpox in the Revolution, and how AI may reshape medical science.

Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. N Engl J Med 2025;393:2284-2286.

This week, we look at new trials on glucocorticoids for pneumonia in Africa, shunting for normal-pressure hydrocephalus, and pegcetacoplan for two rare kidney diseases. We review updated vaccine evidence for Covid-19, RSV, and influenza, and present a case of respiratory decline and muscle weakness. Perspectives explore health care incentives, U.S. global health strategy, and bringing AI-enabled care to rural America.

In this episode, we explore how artificial intelligence is transforming medical decision-making, clinical workflows, and patient outcomes. Our guest, Dr. Zafar Chaudry, Senior Vice President, Chief Digital Officer, and Chief AI & Information Officer at Seattle Children's, breaks down what a true human-AI partnership looks like inside modern healthcare. Watch the full video here. We discuss how AI is being used as a clinical co-pilot, supporting clinicians with faster access to medical knowledge, evidence-based guidelines, and real-time patient data. Dr. Chaudry shares real examples of AI improving diagnostic accuracy, enhancing patient safety, and enabling more personalized treatment plans. You'll also hear insights on the ethical considerations, accountability, and integration challenges that healthcare leaders need to understand as AI becomes more embedded in clinical practice. Topics covered in this episode: How AI supports medical decision-making and clinical workflows Real-world use cases where AI improves patient care and outcomes The role of AI in diagnostics, risk prediction, and personalized medicine Ethical considerations, transparency, and accountability in AI deployment How clinicians and AI can work together without losing the human touch What healthcare leaders should prioritize as AI adoption accelerates This episode is ideal for healthcare executives, clinicians, digital health leaders, and anyone navigating the rapidly evolving landscape of AI in healthcare. Listen to learn how organizations can responsibly and effectively integrate AI to enhance clinical practice and improve patient care. Connect with Dr. Chaudry on LinkedIn. Find Dr. Chaudry's work at https://www.seattlechildrens.org Subscribe and stay at the forefront of the digital healthcare revolution. Watch the full video on YouTube @TheDigitalHealthcareExperience The Digital Healthcare Experience is a hub to connect healthcare leaders and tech enthusiasts. Powered by Taylor Healthcare, this podcast is your gateway to the latest trends and breakthroughs in digital health. Learn more at taylor.com/digital-healthcare About Us: Taylor Healthcare empowers healthcare organizations to thrive in the digital world. Our technology streamlines critical workflows such as procedural & surgical informed consent with patented mobile signature capture, ransomware downtime mitigation, patient engagement and more. For more information, please visit imedhealth.com   The Digital Healthcare Experience Podcast: Powered by Taylor Healthcare Produced by Naomi Schwimmer  Hosted by Chris Civitarese Edited by Eli Banks Music by Nicholas Bach  

Robert Huckman is a professor of business administration at Harvard Business School and a research associate at the National Bureau of Economic Research. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.M. Cutler and R.S. Huckman. Has Corporatization Met Its Match? The Challenge of Making Money by Keeping People Healthy. N Engl J Med 2025;393:2177-2180.

The EAT–Lancet Commission 2025: Health, Sustainability, and Justice The updated EAT–Lancet Commission on Healthy, Sustainable, and Just Food Systems, published in 2025, marks a significant evolution in our understanding of how food connects health, the environment, and social justice. Learn more in today's episode, written by Dr. Shireen Kassam at Plant Based Health Professionals UK #vegan #plantbased #plantbasedbriefing #wfpb #plantbasednutrition #eatlancet #climatechange #climatediet #foodjustice ========================== Original post: https://plantbasedhealthprofessionals.com/review-of-the-plant-based-nutrition-and-lifestyle-medicine-news-october-2025  ========================== RELATED EPISODES: Use search field at PlantBasedBriefing.com/episodes  ========================== Plant-Based Health Professionals UK is an non-profit organization dedicated to providing education and advocacy on whole food plant-based nutrition and lifestyle medicine for prevention and treatment of chronic disease. In addition to practicing conventional medicine, they promote health and well-being using a plant-based lifestyle approach. They reaize there is no doubt that conventional medicine has resulted in some astonishing advances in patient care. However, the current model of healthcare in the UK focuses primarily on treating established disease, rather than emphasising interventions that could prevent or reduce the burden of chronic disease. They provide a valuable resource for the education of healthcare professionals and the general public alike and aim to empower individuals to take control of their own health. Dr. Shireen Kassam founded PBHP UK in 2018. She's a certified lifestyle medicine physician and author of the book, Eating Plant-Based, Scientific Answers to Your Nutrition Questions, co-authored with her sister Zahra, was published in January 2022. She has also co-edited the textbook Plant-Based Nutrition in Clinical Practice, published in September 2022. Learn more at https://plantbasedhealthprofessionals.com/  ============================== FOLLOW PLANT BASED BRIEFING ON: YouTube: https://www.youtube.com/@plantbasedbriefing     Spotify: https://open.spotify.com/show/2GONW0q2EDJMzqhuwuxdCF?si=2a20c247461d4ad7 Apple Podcasts: https://podcasts.apple.com/us/podcast/plant-based-briefing/id1562925866 Your podcast app of choice: https://pod.link/1562925866 Facebook: https://www.facebook.com/PlantBasedBriefing   LinkedIn: https://www.linkedin.com/company/plant-based-briefing/   Instagram: https://www.instagram.com/plantbasedbriefing/   

In this episode, Dr. Diane interviews Amardeep Bedi, a former optometrist who pivoted from clinical practice to practice enhancement coaching. Amardeep shares his journey of recognizing the need for change, the challenges he faced, and how he created Mastery Coaching to help other practice owners find fulfillment and success. The conversation emphasizes the importance of self-belief, personal growth, and the need to define success on one's own terms. Takeaways Amardeep Bedi transitioned from clinical optometry to coaching to find personal fulfillment. He recognized the importance of self-belief in achieving one's goals, where many clinicians feel bored and unfulfilled in their careers, leading to a desire for change. Mastery Coaching helps practice owners optimize their businesses for a better work-life balance. Taking time for self-reflection is crucial for personal and professional growth. Success should be defined on individual terms, not societal expectations. Amardeep emphasizes the need for kindness towards oneself during transitions. Building freedom into one's life is essential for happiness. The journey of pivoting can lead to greater impact and fulfillment. It's important to trust oneself and take the leap towards change.   MORE WAYS TO CONNECT: Follow our LinkedIn page:  https://www.linkedin.com/company/life-beyond-clinical-practice/    Book a Strategy Call with Dr Diane https://calendly.com/lbcp/strategy-call    Join the Movement on Instagram: @lifebeyondclinicalpractice  Rate and Review the show on Apple Podcasts https://podcasts.apple.com/us/podcast/life-beyond-clinical-practice-healthcare-careers-professional/id1713086617      Enjoyed this episode?  We think you'll enjoy this one too https://podcasts.apple.com/ca/podcast/102-why-loving-yourself-is-key-to-authentically-thriving/id1713086617?i=1000717138734       

Join legendary clinical herbalist Paul Bergner in an intimate, living-room conversation on herbalism as a calling, not just a career. With over 50 years of hands-on clinical practice, teaching, and mentorship, Paul shares rare insight into what truly shapes a great herbalist—diet, sleep, case-based learning, critical thinking, and deep relationship with plants. In this wide-ranging monologue, Paul reflects on: His early work in prisons and community clinics Why follow-ups matter more than textbooks How herbalists are really trained The role of "calling" in healing work Why the future of herbalism is becoming simpler, not more complex This is a masterclass in lived experience from one of the most influential medical herbalists of our time. WATCH THIS EPISODE ON YOUTUBE Learn more about Paul and his work | North American Institute of Medical Herbalism | NAIMH.com Herbalism in your neck of the woods. HerbRally | HerbRally.com DISCLAIMER This content is for educational and entertainment purposes only. It is not intended to diagnose, treat, or cure any disease. Always consult with a qualified healthcare provider before making changes to your health regimen.

This week, we look at new studies on early aspirin discontinuation after myocardial infarction, an antiviral pill for dengue prevention, and CRISPR-based gene editing for lipid disorders. We review bedside clinical teaching and present a complex case of seizures and visual disturbances. Perspectives explore antidepressant safety in pregnancy, restoring trust in public health, academic medical centers' venture investments, and a young physician's wrinkled white coat.

Nishant Uppal is an instructor in medicine at Massachusetts General Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. N. Uppal and Z. Song. Venture Capital Investments by U.S. Academic Medical Centers. N Engl J Med 2025;393:2077-2080.

Send us a message with this link, we would love to hear from you. Standard message rates may apply.Clear guidance on benefits, risks, and how the FDA's label changes shift conversations in the exam room about HRTNikki's Corner• Philly's first Michelin stars and what the tiers mean• Flying taxis in Dubai • A cold case solved by college criminology studentsLearning • What HRT is, routes of therapy, and who benefits• Reframing WHI-era fears with age and timing data• FDA label changes and clinical implications• Contraindications and safer use considerations• Women's health bias and the cost of not listening• Practical steps for shared decisions with cliniciansReferencesThe 2022 Hormone Therapy Position Statement of the North American Menopause Society. Menopause (New York, N.Y.). 2022;29(7):767-794. doi:10.1097/GME.0000000000002028.Management of Menopausal Symptoms: A Review. Crandall CJ, Mehta JM, Manson JE. JAMA. 2023;329(5):405-420. doi:10.1001/jama.2022.24140.Hormone Therapy for Postmenopausal Women. Pinkerton JV. The New England Journal of Medicine. 2020;382(5):446-455. doi:10.1056/NEJMcp1714787.Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: US Preventive Services Task Force Recommendation Statement. Grossman DC, Curry SJ, Owens DK, et al. JAMA. 2017;318(22):2224-2233. doi:10.1001/jama.2017.18261.Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. Gartlehner G, Patel SV, Reddy S, et al. JAMA. 2022;328(17):1747-1765. doi:10.1001/jama.2022.18324.Hormone Therapy in the Postmenopausal Years: Considering Benefits and Risks in Clinical Practice. Genazzani AR, Monteleone P, Giannini A, Simoncini T. Human Reproduction Update. 2021;27(6):1115-1150. doi:10.1093/humupd/dmab026.Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Flores VA, Pal L, Manson JE. Endocrine Reviews. 2021;42(6):720-752. doi:10.1210/endrev/bnab011.The Women's Health Initiative Randomized Trials and Clinical Practice: A Review. Manson JE, Crandall CJ, Rossouw JE, et al. JAMA. 2024;331(20):1748-1760. doi:10.1001/jama.2024.6542.Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: US Preventive Services Task Force Recommendation Statement. Mangione CM, Barry MJ, NicSupport the showSubscribe to Our Newsletter! Production and Content: Edward Delesky, MD & Nicole Aruffo, RNArtwork: Olivia Pawlowski

Dr. Peter Addy, LPC, LMHC, integrates foundational set and setting concepts with core therapeutic competencies to support clinicians working with clients who use psychedelics while outlining ethical responses, harm reduction strategies, and ways to incorporate these experiences into ongoing treatment. Interview with Elizabeth Irias. Earn CE credit for listening to this episode by joining our low-cost membership for unlimited podcast CE credits for an entire year, with some of the strongest CE approvals in the country (APA, NBCC, ASWB, and more). Learn, grow, and shine with Clearly Clinical Continuing Ed by visiting https://ClearlyClinical.com.

This week, we look at new research on potassium optimization in patients with defibrillators, reducing antihypertensive therapy in nursing homes, an mRNA influenza vaccine, and belzutifan for rare neuroendocrine tumors. We review long QT syndrome and present a case of abnormal behavior and seizures in a young man. We also explore perspectives on primary care reform, tobacco cessation in HIV and tuberculosis care, corporate control in health care, and the simple power of compassion with ice cream.

Send us a textIn this episode of The Incubator Podcast, Ben and Daphna sit down with Dr. Alex Kemper, Division Chief of Primary Care Pediatrics at Nationwide Children's Hospital and Editor-in-Chief of Pediatrics. Dr. Kemper served as chair of the American Academy of Pediatrics subcommittee that authored the 2022 revision of the neonatal hyperbilirubinemia guidelines.Together, they explore the motivations behind revisiting the 2004 guideline, the major changes introduced, and how these revisions are shaping clinical care. Dr. Kemper explains why treatment thresholds for phototherapy were raised, the careful balance between avoiding unnecessary interventions and preventing kernicterus, and the rationale for moving away from the risk stratification nomogram. The discussion highlights phototherapy as an effective but not benign therapy—one that can disrupt bonding, prolong hospitalization, and create family stress when overused.Listeners will gain insight into the complexities of evidence review, the challenges of consensus-building over eight years of work, and the importance of shared decision-making and reliable follow-up after discharge. This conversation not only demystifies the new guidelines but also reframes the way clinicians think about jaundice management, risk stratification, and the broader impact on families.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!